Article
03 Oct 2025
Life Sciences And Medtech Policy Update: Key Things To Know Q4 2025
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
04 Apr 2025
A Look Ahead In Life Sciences: What We Are Tracking In The Second Quarter Of 2025 And Beyond
Article
13 Mar 2025
US Emerging As Top Global Medtech Destination
Article
04 Feb 2025
FDA Publishes Its First Draft Guidance On Use Of Artificial Intelligence In The Development Of Drugs And Biological Products
Article
06 Nov 2024
FDA Approvals Of AI Medical Devices Rise Rapidly
Article
03 Oct 2024
A Look Ahead In Life Sciences: What We Are Tracking In The Fourth Quarter Of 2024 And Beyond
Article
04 Jun 2024
Lawsuit Filed Challenging FDA Final Rule Regulating Laboratory Developed Tests
Article
04 Jun 2024
Designating A Platform Technology: FDA's Long-Awaited Draft Guidance
Article
22 May 2024
FDA Finalizes Rule And Sets Course To Phase In Oversight Of Laboratory Developed Tests
Article
06 May 2024
FDA Issues Final Rule On Regulation Of Laboratory Developed Tests
Article
05 Apr 2024
A Look Ahead In Life Sciences: What We Are Tracking In Q2 2024 And Beyond
Article
19 Mar 2024
FDA's Laboratory Developed Test (LDT) Final Rule Under OIRA Review; Subcommittee On Health To Hold Hearing On Regulation Of Diagnostic Tests
Article
16 Jan 2024
Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.
Article
09 Jan 2024
A Look Ahead In Life Sciences: What We Are Tracking In Q1 2024 And Beyond
Article
13 Dec 2023
FDA Targets April 2024 For Laboratory Developed Test (LDT) Final Rule
Article
03 Nov 2023
White House Unveils Landmark Executive Order On Safe, Secure, And Trustworthy Artificial Intelligence
Article
01 Nov 2023
Newly Launched: Goodwin's Laboratory Developed Tests Resource Page
Article
20 Oct 2023
Recent FDA Initiatives To Support Development Of Individualized Cell And Gene Therapies And Rare Disease Therapies
Article
16 Oct 2023
FDA's Proposed Rule For Oversight Of Laboratory Developed Tests: Part II: FDA's Proposed Phaseout Policy – Key Considerations & Open Questions
Article
10 Oct 2023
A Look Ahead In Life Sciences: What We Are Tracking In Q4 2023 And Beyond